Summary
Updated Aug 31, 2026
Frank D. Heuszel is Chief Executive Officer, Director of IMPACT BIOMEDICAL INC. (IBO). 2 SEC Form 4 filings on record, most recently on 9 December 2024. Most recent open-market trade: bought $1K of IBO on 9 December 2024. Lifetime open-market purchases: $4K. Historical track record: 1/5 stars across 3 tracked purchases.
Recent Transactions
3Every recent SEC Form 4 transaction Frank D. Heuszel has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 0% |
| 90-day win rate | 0% |
| Avg 5-day return | -3.57% |
| Avg 30-day return | -32.71% |
| Avg 90-day return | -30.98% |
| Best 30-day return | -15.35% |
Trading Pattern
InsiderAlpha's records for Frank D. Heuszel go back to 2024: 2 primary Form 4 filings, an average of 0.7 per year. The typical open-market purchase is $1K (3 buys totaling $4K). The largest single buy on record is $1K of IBO in 2024. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Frank D. Heuszel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- DSS, INC. - $88K of IBO open-market activity in the last 12 months
- Jason Grady - $33K of IBO open-market activity in the last 12 months
- Todd D. Macko - $25K of IBO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Frank D. Heuszel?
Frank D. Heuszel is a corporate insider, tracked as Chief Executive Officer, Director of IMPACT BIOMEDICAL INC. (IBO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Frank D. Heuszel last file a Form 4?
The most recent primary Form 4 on record is dated 9 December 2024, one of 2 filings going back to 2024.
Has Frank D. Heuszel been buying or selling stock?
Recorded transactions: 3 open-market purchases ($4K) and 0 open-market sales across all tracked filings.
How accurate is Frank D. Heuszel's historical track record?
Across 3 tracked purchases, Frank D. Heuszel averaged -32.7% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of Frank D. Heuszel's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Frank D. Heuszel and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial